Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
5.70 via halifax
being offered 5.70 to sell . No thankS
being offered 5.02
5p paid again
via Halifax right now.
4.20 ON BID 4.25 to buy.
Its was NT to sell for most of the morning via Halifax , now we are up .
something going on . GLA
Something going on now , just opened it up.
4.10 on ask via Halifax looking good
Anumso Gold Corp ('Anumso')
So more Money to come from this sale.
So more money to come from the sale of this.
So more money to more from this sale . Fantastic RNS
We have agreed with our Joint Venture partner at Anumso, Desert Gold (Ashanti Gold and Desert Gold merged towards the end of September 2019), to seek a buyer for the Anumso gold project. We have had discussions with a potential buyer and will announce the outcome in due course.
JUST went to 3.70 on Halifax.
Not many shares in issue , see below list. Halifax restricting buying to £1500.00 and bid slightly moved up . GLA
Total issued share capital: 167,441,000 Ordinary Shares
Total voting capital: 167,441,000 Ordinary Shares
Percentage issued share capital not in public hands: 11.58%
There are no restrictions on the transfer of AIM securities
As of 29 May 2019, the following are registered as being interested in 3% or more of the Company's ordinary share capital:
Shareholder Number of Ordinary Shares % Holding
Martin Ooi 16,746,192 10.00
Chase Nominees Limited ( FIL Limited ) 14,913,000 8.91
HSDL Nominees Limited 13,424,179 8.02
TD Direct Investing Nominees (Europe) Limited 10,551,008 6.30
Fitel Nominees Limited 10,065,000 6.01
Vidacos Nominees Limited 9,182,504 5.48
Canaccord Genuity Group Inc 8,040,400 4.80
Global Custody 8,400,000 5.02
HSDL Nominees Limited 7,877,054 4.70
Hargreaves Lansdown (Nominees) Limited 6,126,300 3.66
Barclays Direct Investing Nominees Limited 5,747,085 3.43
HALIFAX offering 2.46 on the bid right now
Hemogenyx has successfully constructed and in vitro tested Chimeric Antigen Receptor (CAR) programmed T cells (HEMO-CAR-T) for potential treatment of AML. HEMO-CAR was constructed using Hemogenyx's proprietary humanized monoclonal antibody against a target on the surface of AML cells. The Company has demonstrated that HEMO-CAR was able to programme human T cells (converted them into HEMO-CAR-T) to identify and destroy human AML derived cells in vitro.
Buyers coming back in before the close
Just went out on twitter
More
Replying to @barondaytrading
Lek should be your biggest imho
1 reply0 retweets0 likes
Reply 1 Retweet Like
Baron Investments
?
@barondaytrading
1m1 minute ago
More
I have increased.
Also , 2 million shares traded on Nex so far , the majority are buys .
Looking Good Today.
In Auction at the moment.
10.09 via Halifax
Just looking at the RNS released on Friday , Baron Capital RNS was crossed on the 30/12 prior to the announcement .
On Thursday and Friday there was a lot of 50k block buys going through on AT TRADES.
Will be interesting to if Barons Capital have increased their holdings with a new RNS this week coming